Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study.

Feldman L, Shani M, Sinuani I, Beberashvili I, Weissgarten J.

Hemodial Int. 2012 Oct;16(4):512-6. doi: 10.1111/j.1542-4758.2012.00702.x. Epub 2012 Apr 30.

PMID:
22541137
2.

N-acetylcysteine improves residual renal function in peritoneal dialysis patients: a pilot study.

Feldman L, Shani M, Efrati S, Beberashvili I, Yakov-Hai I, Abramov E, Sinuani I, Rosenberg R, Weissgarten J.

Perit Dial Int. 2011 Sep-Oct;31(5):545-50. doi: 10.3747/pdi.2009.00263. Epub 2010 Aug 12.

PMID:
20705950
3.

Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial.

Ahmadi F, Abbaszadeh M, Razeghi E, Maziar S, Khoidaki SD, Najafi MT, Lessan-Pezeshki M.

Clin Exp Nephrol. 2017 Apr;21(2):342-349. doi: 10.1007/s10157-016-1277-5. Epub 2016 May 20.

PMID:
27206513
4.
5.

Effect of iodinated contrast agents on residual renal function in PD patients.

Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E.

Nephrol Dial Transplant. 2006 Apr;21(4):1040-5. Epub 2005 Dec 13.

PMID:
16352623
6.

Effectiveness of furosemide in patients on peritoneal dialysis.

Flinn A, Ledger S, Blake P.

CANNT J. 2006 Jul-Sep;16(3):40-4.

PMID:
17061696
7.

Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis.

Caravaca F, Arrobas M, Dominguez C.

Perit Dial Int. 1999 Jul-Aug;19(4):350-6.

PMID:
10507816
8.
9.
11.

Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.

Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG.

Perit Dial Int. 2000 Jul-Aug;20(4):429-38.

PMID:
11007375
12.
13.

Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.

McCarthy JT, Jenson BM, Squillace DP, Williams AW.

Am J Kidney Dis. 1997 Apr;29(4):576-83.

PMID:
9100048
14.

The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients.

Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, Ohtani A, Nakashima Y.

Nephrol Dial Transplant. 2000 Mar;15(3):396-401.

PMID:
10692527
15.

Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors.

Lang SM, Bergner A, Töpfer M, Schiffl H.

Perit Dial Int. 2001 Jan-Feb;21(1):52-7.

PMID:
11280496
16.

Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.

Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.

Rev Invest Clin. 2012 Jul-Aug;64(4):315-21.

PMID:
23227581
17.

Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis?

Chadha V, Blowey DL, Warady BA.

Perit Dial Int. 2001;21 Suppl 3:S179-84.

PMID:
11887816
18.

Predictors of decline of residual renal function in new peritoneal dialysis patients.

Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P.

Perit Dial Int. 2003 May-Jun;23(3):276-83.

PMID:
12938830
19.

The effect of peritoneal dialysis method on residual renal function in children.

Roszkowska-Blaim M, Skrzypczyk P, Jander A, Tkaczyk M, Bałasz-Chmielewska I, Zurowska A, Drozdz D, Pietrzyk JA.

Adv Perit Dial. 2012;28:112-9.

PMID:
23311226
20.

Determination of residual renal function with iohexol clearance in hemodialysis patients.

Swan SK, Halstenson CE, Kasiske BL, Collins AJ.

Kidney Int. 1996 Jan;49(1):232-5.

Supplemental Content

Support Center